AffiliationDepartment of Endocrinology, Christie Hospital, Manchester, UK.
MetadataShow full item record
AbstractAcromegaly is a disfiguring and disabling illness which, when inadequately treated, reduces life expectancy. An implication of the ability to offer effective treatment is the increased onus on physicians of all sorts to ensure acromegaly is diagnosed and treated as early as possible. To this end, criteria for the diagnosis of acromegaly have been proposed in the consensus statement of Giustina et al. However, other data suggest that the proposed criteria are not rigorous enough and strict adherence to the guidelines would result in failure to diagnose a significant number of patients. A review of published experience suggests that the combination of a GH nadir during an oral glucose tolerance test of <0.25 microg/l plus a normal age-related insulin growth factor-I level makes the diagnosis of acromegaly extremely unlikely.
CitationPitfalls in the diagnosis of acromegaly. 2004, 62 Suppl 3:74-8 Horm. Res.
- Review of Cortina criteria for the diagnosis of acromegaly.
- Authors: degli Uberti EC, Bondanelli M, Ambrosio MR, Zatelli MC
- Issue date: 2005
- Current concepts in the biochemical assessment of the patient with acromegaly.
- Authors: Freda PU
- Issue date: 2003 Aug
- Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly.
- Authors: Colao A, Pivonello R, Cavallo LM, Gaccione M, Auriemma RS, Esposito F, Cappabianca P, Lombardi G
- Issue date: 2006 Aug
- Discordant nadir GH after oral glucose and IGF-I levels on treated acromegaly: refining the biochemical markers of mild disease activity.
- Authors: Elias PC, Lugao HB, Pereira MC, Machado HR, Castro Md, Moreira AC
- Issue date: 2010 Jan
- Hormonal diagnosis of GH hypersecretory states.
- Authors: Grottoli S, Gasco V, Ragazzoni F, Ghigo E
- Issue date: 2003